A powerful combination of cagrilintide and semaglutide for synergistic weight loss. Dual-pathway appetite suppression for extreme results.
"Combination therapy shows enhanced weight loss beyond either agent alone."
Wholesale pricing. Contact us for volume discounts and custom orders.
A GLP-1 receptor agonist that mimics the naturally occurring GLP-1 hormone. Stimulates insulin secretion, suppresses appetite, and slows gastric emptying for powerful weight management.
A dual GIP/GLP-1 receptor agonist that activates both incretin receptors for superior weight loss. Regulates blood sugar, suppresses appetite, and increases feelings of fullness.
An investigational triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors. Regulates appetite, increases energy expenditure, and improves metabolic function for extreme weight loss.